*
Cellex, Inc. qSARS-CoV-2 IgG/IgM Rapid Test Cassette
The Cellex, Inc. qSARS-CoV-2 IgG/IgM Rapid Test, which has received an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA), is indicated for the qualitative detection and differentiation of IgM and IgG antibodies against SARS-CoV-2 in serum, plasma (EDTA or citrate), or venipuncture whole blood from individuals suspected of COVID-19 by a healthcare provider. Emergency use of this test is limited to authorized laboratories.
Test Type: Rapid Antibody (IgM/IgG)
Specimen Type: Serum, plasma (EDTA or citrate), or venipuncture whole blood
Turnaround Time: 15-20 minutes, results are not valid after 20 minutes
FDA Status: EUA granted
CLIA Complexity: Moderately/highly complex
Specimen Type: Serum, plasma (EDTA or citrate), or venipuncture whole blood
Turnaround Time: 15-20 minutes, results are not valid after 20 minutes
FDA Status: EUA granted
CLIA Complexity: Moderately/highly complex
Ordering information:
Contact your Cardinal Health Laboratory Products Representative to order or complete the form below.
| Material # | Description | Pkg string |
|---|---|---|
| 5515C025 | qSARS-CoV-2 IgG/IgM Rapid Test Cassette* |
25 kits/carton, 400 cartons/unit |
* Controls sold separately
*
*
Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.
